Ohtake, A., Abe, Y., Murayama, K., Shiraishi, H., Osaka, H., Kumada, S., Ito, T., Kondo, H., Hamada, Y., Suzuki-Ajihara, S., Arao, M., Ueda, Y., Nagai, K., Ichimoto, K., Matsunaga, A., Kashii, H., Nakajima, Y., Nakagawa, H., Kurose, S., Fukuda, K., Takahashi, K., Yamauchi, M., Nakajima, M. (2026). A phase III double-blind, placebo-controlled, randomized withdrawal trial of 5‑aminolevulinic acid hydrochloride with sodium ferrous citrate for efficacy and safety in patients diagnosed as Leigh syndrome. PLoS ONE. https://doi.org/10.1371/journal.pone.0332283